MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients

Phase 2
Not yet recruiting
Conditions
Colon Cancer
Interventions
First Posted Date
2024-03-08
Last Posted Date
2024-03-08
Lead Sponsor
Fudan University
Target Recruit Count
25
Registration Number
NCT06301386
Locations
🇨🇳

Anyang Tumor Hospital, Anyang, Henan, China

🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery

Not Applicable
Recruiting
Conditions
Distal Pancreatectomy
Diagnosis
Pancreatic Cancer
Pancreatoduodenectomy
Interventions
Device: probe confocal laser endomicroscopy
First Posted Date
2024-03-04
Last Posted Date
2024-03-04
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT06289803
Locations
🇨🇳

Huadong Hospital affiliated to Fudan University, Shanghai, Shanghai, China

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Phase 2
Recruiting
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2024-02-29
Last Posted Date
2024-02-29
Lead Sponsor
Fudan University
Target Recruit Count
65
Registration Number
NCT06285019
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer

Phase 2
Not yet recruiting
Conditions
Locally Advanced Rectal Cancer
Neoadjuvant Therapy
Interventions
Drug: PD-1 antibody
Radiation: Short-course radiotherapy
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
Fudan University
Target Recruit Count
198
Registration Number
NCT06281405
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients

Not Applicable
Not yet recruiting
Conditions
Hiv
Diet, Healthy
Cardiovascular Diseases
Interventions
Dietary Supplement: gut microbiota-targeted dietary intervention
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
Fudan University
Target Recruit Count
106
Registration Number
NCT06279819
Locations
🇨🇳

Fudan University, Shanghai, Shanghai, China

Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing Techniques

Not Applicable
Not yet recruiting
Conditions
Pain, Postoperative
Gastrointestinal Tumors
Surgical Wound Infection
Interventions
Procedure: Non-Dressing of Surgical Wound
Procedure: Regular Dressing Change of Surgical Wound
First Posted Date
2024-02-16
Last Posted Date
2024-04-02
Lead Sponsor
Fudan University
Target Recruit Count
816
Registration Number
NCT06263205
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Not Applicable
Not yet recruiting
Conditions
Small Cell Lung Cancer Recurrent
Interventions
First Posted Date
2024-02-14
Last Posted Date
2024-02-14
Lead Sponsor
Fudan University
Target Recruit Count
39
Registration Number
NCT06258642
Locations
🇨🇳

Cancer hospital Fudan University, Shanghai, Shanghai, China

A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal Endometriosis

Recruiting
Conditions
Gastrointestinal Function
Quality of Life
Pregnancy Outcomes
Interventions
Procedure: disc resection
Procedure: segmental resection
First Posted Date
2024-02-12
Last Posted Date
2024-02-12
Lead Sponsor
Fudan University
Target Recruit Count
90
Registration Number
NCT06254716
Locations
🇨🇳

OB & GYN Hospital of Fudan University, Shanghai, Shanghai, China

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

Phase 3
Recruiting
Conditions
Pancreatic Adenocarcinoma
Interventions
Drug: Gemcitabine, Nab-paclitaxel, Irinotecan
Radiation: Intensity-Modulated Radiation Therapy (IMRT)
First Posted Date
2024-02-09
Last Posted Date
2024-05-23
Lead Sponsor
Fudan University
Target Recruit Count
210
Registration Number
NCT06250972
Locations
🇨🇳

Shanghai Cancer Center, Shanghai, Shanghai, China

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Phase 2
Recruiting
Conditions
Prostate Cancer Metastatic
Castration-resistant Prostate Cancer
Interventions
Radiation: Stereotactic body radiotherapy
First Posted Date
2024-02-09
Last Posted Date
2024-02-20
Lead Sponsor
Fudan University
Target Recruit Count
30
Registration Number
NCT06251492
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

🇨🇳

Fudan University Shanghai Cancer Center Xiamen Branch., Xiamen, Fujian, China

🇨🇳

Fujian Cancer Hospital, Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath